HK Stock MarketDetailed Quotes

06667 MEGA GENOMICS

Watchlist
  • 9.100
  • -0.050-0.55%
Market Closed Apr 26 16:08 CST
2.15BMarket Cap65.00P/E (TTM)

MEGA GENOMICS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
(Q6)Jun 30, 2020
Turnover
3.82%151.3M
1.29%98.88M
-38.56%145.73M
0.81%97.62M
16.71%237.19M
3.62%152.4M
-5.59%96.83M
64.28%203.22M
--147.07M
--102.56M
Operating income
3.82%151.3M
1.29%98.88M
-38.56%145.73M
0.81%97.62M
16.71%237.19M
3.62%152.4M
-5.59%96.83M
64.28%203.22M
147.07M
102.56M
Cost of sales
1.56%-63M
-1.14%-33.58M
9.23%-64M
-2.41%-33.2M
-23.75%-70.51M
-18.39%-50.66M
-0.37%-32.42M
-25.99%-56.98M
---42.79M
---32.3M
Operating expenses
1.56%-63M
-1.14%-33.58M
9.23%-64M
-2.41%-33.2M
-23.75%-70.51M
-18.39%-50.66M
-0.37%-32.42M
-25.99%-56.98M
-42.79M
-32.3M
Gross profit
8.04%88.3M
1.37%65.3M
-50.97%81.72M
0.01%64.42M
13.97%166.68M
-2.44%101.74M
-8.33%64.41M
86.35%146.24M
104.28M
70.26M
Selling expenses
11.92%-30.71M
-4.69%-16.52M
-51.73%-34.86M
-116.65%-15.78M
-17.98%-22.98M
-69.17%-13.04M
-14.18%-7.29M
-293.91%-19.48M
---7.71M
---6.38M
Administrative expenses
-3.67%-44.5M
-63.77%-24.16M
-86.91%-42.93M
-48.50%-14.75M
-23.80%-22.97M
-11.96%-14.82M
-1.01%-9.93M
-19.06%-18.55M
---13.23M
---9.83M
Impairment and provision
144.79%11.58M
5,228.57%10.41M
-319.33%-25.85M
79.33%-203K
-949.17%-6.17M
14.55%-8.46M
84.11%-982K
111.25%726K
---9.9M
---6.18M
-Other impairment is provision
144.79%11.58M
5,228.57%10.41M
-319.33%-25.85M
79.33%-203K
-949.17%-6.17M
14.55%-8.46M
84.11%-982K
111.25%726K
---9.9M
---6.18M
Special items of operating profit
933.96%12.64M
160.34%7.54M
110.38%1.22M
-535.87%-12.49M
-568.15%-11.77M
268.98%6.22M
193.35%2.87M
-60.57%2.52M
--1.69M
--977K
Operating profit
280.21%37.3M
100.92%42.57M
-120.14%-20.7M
-56.83%21.19M
-7.77%102.79M
-4.63%71.65M
0.48%49.08M
92.57%111.45M
75.13M
48.85M
Financing cost
-56.05%-1.12M
34.48%-266K
89.59%-719K
93.83%-406K
58.25%-6.91M
46.07%-6.76M
21.89%-6.58M
15.49%-16.55M
---12.53M
---8.43M
Adjustment items of  earning before tax
----
----
----
----
----
---13.45M
----
----
----
----
Earning before tax
268.92%36.18M
103.56%42.3M
-122.34%-21.42M
-51.10%20.78M
1.03%95.88M
-17.82%51.44M
5.14%42.49M
147.84%94.9M
62.6M
40.42M
Tax
-261.61%-6.14M
-141.03%-7.19M
122.53%3.8M
58.48%-2.98M
-6.71%-16.87M
12.41%-9.82M
-1.48%-7.18M
-83.77%-15.81M
---11.21M
---7.08M
After-tax profit from continuing operations
270.50%30.04M
97.29%35.12M
-122.30%-17.62M
-49.60%17.8M
-0.10%79.02M
-19.00%41.63M
5.92%35.31M
166.40%79.1M
51.39M
33.34M
Earning after tax
270.50%30.04M
97.29%35.12M
-122.30%-17.62M
-49.60%17.8M
-0.10%79.02M
-19.00%41.63M
5.92%35.31M
166.40%79.1M
51.39M
33.34M
Profit attributable to shareholders
270.50%30.04M
97.29%35.12M
-122.30%-17.62M
-49.60%17.8M
-0.10%79.02M
-19.00%41.63M
5.92%35.31M
166.40%79.1M
51.39M
33.34M
Basic earnings per share
255.56%0.14
77.78%0.16
-114.52%-0.09
-86.36%0.09
0.62
0.41
0.66
Diluted earnings per share
255.56%0.14
77.78%0.16
-114.52%-0.09
-86.36%0.09
0.62
0.41
0.66
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
--
Ernst & Young
--
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020(Q6)Jun 30, 2020
Turnover 3.82%151.3M1.29%98.88M-38.56%145.73M0.81%97.62M16.71%237.19M3.62%152.4M-5.59%96.83M64.28%203.22M--147.07M--102.56M
Operating income 3.82%151.3M1.29%98.88M-38.56%145.73M0.81%97.62M16.71%237.19M3.62%152.4M-5.59%96.83M64.28%203.22M147.07M102.56M
Cost of sales 1.56%-63M-1.14%-33.58M9.23%-64M-2.41%-33.2M-23.75%-70.51M-18.39%-50.66M-0.37%-32.42M-25.99%-56.98M---42.79M---32.3M
Operating expenses 1.56%-63M-1.14%-33.58M9.23%-64M-2.41%-33.2M-23.75%-70.51M-18.39%-50.66M-0.37%-32.42M-25.99%-56.98M-42.79M-32.3M
Gross profit 8.04%88.3M1.37%65.3M-50.97%81.72M0.01%64.42M13.97%166.68M-2.44%101.74M-8.33%64.41M86.35%146.24M104.28M70.26M
Selling expenses 11.92%-30.71M-4.69%-16.52M-51.73%-34.86M-116.65%-15.78M-17.98%-22.98M-69.17%-13.04M-14.18%-7.29M-293.91%-19.48M---7.71M---6.38M
Administrative expenses -3.67%-44.5M-63.77%-24.16M-86.91%-42.93M-48.50%-14.75M-23.80%-22.97M-11.96%-14.82M-1.01%-9.93M-19.06%-18.55M---13.23M---9.83M
Impairment and provision 144.79%11.58M5,228.57%10.41M-319.33%-25.85M79.33%-203K-949.17%-6.17M14.55%-8.46M84.11%-982K111.25%726K---9.9M---6.18M
-Other impairment is provision 144.79%11.58M5,228.57%10.41M-319.33%-25.85M79.33%-203K-949.17%-6.17M14.55%-8.46M84.11%-982K111.25%726K---9.9M---6.18M
Special items of operating profit 933.96%12.64M160.34%7.54M110.38%1.22M-535.87%-12.49M-568.15%-11.77M268.98%6.22M193.35%2.87M-60.57%2.52M--1.69M--977K
Operating profit 280.21%37.3M100.92%42.57M-120.14%-20.7M-56.83%21.19M-7.77%102.79M-4.63%71.65M0.48%49.08M92.57%111.45M75.13M48.85M
Financing cost -56.05%-1.12M34.48%-266K89.59%-719K93.83%-406K58.25%-6.91M46.07%-6.76M21.89%-6.58M15.49%-16.55M---12.53M---8.43M
Adjustment items of  earning before tax -----------------------13.45M----------------
Earning before tax 268.92%36.18M103.56%42.3M-122.34%-21.42M-51.10%20.78M1.03%95.88M-17.82%51.44M5.14%42.49M147.84%94.9M62.6M40.42M
Tax -261.61%-6.14M-141.03%-7.19M122.53%3.8M58.48%-2.98M-6.71%-16.87M12.41%-9.82M-1.48%-7.18M-83.77%-15.81M---11.21M---7.08M
After-tax profit from continuing operations 270.50%30.04M97.29%35.12M-122.30%-17.62M-49.60%17.8M-0.10%79.02M-19.00%41.63M5.92%35.31M166.40%79.1M51.39M33.34M
Earning after tax 270.50%30.04M97.29%35.12M-122.30%-17.62M-49.60%17.8M-0.10%79.02M-19.00%41.63M5.92%35.31M166.40%79.1M51.39M33.34M
Profit attributable to shareholders 270.50%30.04M97.29%35.12M-122.30%-17.62M-49.60%17.8M-0.10%79.02M-19.00%41.63M5.92%35.31M166.40%79.1M51.39M33.34M
Basic earnings per share 255.56%0.1477.78%0.16-114.52%-0.09-86.36%0.090.620.410.66
Diluted earnings per share 255.56%0.1477.78%0.16-114.52%-0.09-86.36%0.090.620.410.66
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion----Unqualified Opinion----
Auditor Ernst & Young--Ernst & Young--Ernst & Young----Ernst & Young----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg